CymitQuimica logo

Evogliptin

Ref. 3D-XYB10229

2mg
Discontinued
5mg
Discontinued
25mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

Evogliptin
Biosynth

    Product Information

    Name:Evogliptin
    Brand:Biosynth
    Description:Evogliptin is an oral anti-diabetic drug that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is a potent inhibitor of P-glycoprotein, which may affect its absorption, distribution, metabolism and excretion. Evogliptin has been shown to reduce the risk of congestive heart failure in patients with type 2 diabetes mellitus by reducing inflammation and oxidative stress. The pharmacokinetics of evogliptin have been studied in vitro using human macrophages and in vivo using healthy volunteers and patients with type 2 diabetes mellitus. Evogliptin also reduces hepatic steatosis and hepatic impairment as well as human macrophages.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:401.4 g/mol
    Formula:C19H26F3N3O3
    Purity:Min. 95%

    Inquiry about discontinued product: Evogliptin

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.